Publications

Publication list

Sort by: Date | Author | Title

Zhang BC, Pedersen A, Reinert LS, Li Y, Narita R, Idorn M et al. STING signals to NF-κB from late endolysosomal compartments using IRF3 as an adaptor. Nature Immunology. 2025 Nov;26(11):1916-1930. Epub 2025 Sept 19. doi: 10.1038/s41590-025-02283-8
Wedge E, Ahmadov U, Hansen TB, Gao Z, Tulstrup M, Côme C et al. Impact of U2AF1 mutations on circular RNA expression in myelodysplastic neoplasms. Leukemia. 2023 May;37(5):1113-1125. Epub 2023 Mar 15. doi: 10.1038/s41375-023-01866-4
Vakulskas CA, Dever DP, Rettig GR, Turk R, Jacobi AM, Collingwood MA et al. A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nature Medicine. 2018;24(8):1216-1224. doi: 10.1038/s41591-018-0137-0
Terkelsen T, Yumiceba V, Kim J, Melo US, Axelgaard E, Febbraro F et al. Position effect at the SOX3 locus by an interchromosomal insertion causes hereditary spastic paraplegia. American Journal of Human Genetics. 2026 Aug 6;113(8):1736-1753. Epub 2026 Jul 24. doi: 10.1016/j.ajhg.2026.07.001
Staunstrup NH, Sharma N, Bak RO, Svensson L, Petersen TK, Aarenstrup L et al. A Sleeping Beauty DNA transposon-based genetic sensor for functional screening of vitamin D3 analogues. BMC Biotechnology. 2011 Apr 7;11(1):33. doi: 10.1186/1472-6750-11-33
Skov TW, Wolff JH, Haslund D, Revenfeld AL, van de Venn L, Dorset SR et al. Treatment of GATA2 deficiency by allele-specific CRISPR-Cas9-directed gene correction in hematopoietic stem cells. Molecular Therapy. 2025 Nov 5;33(11):5644-5660. Epub 2025 Jul 29. doi: 10.1016/j.ymthe.2025.07.038
Skoczek D, Hohendorff J, Malecki MT, Roig-Merino A, Bak RO, Kachamakova-Trojanowska N. CRISPR/Cas9-based repair of a heterozygous HNF1A mutation in patient-derived hiPSCs. Human Genetics. 2026 Dec;145(1):69. doi: 10.1007/s00439-026-02863-0
Şahin C, Formica TM, Silva A, Della Pelle G, Davis MC, Andersen DG et al. The landscape and trajectory of global CRISPR therapeutics. Molecular Therapy Nucleic Acids. 2026 Sept 8;37(3):103011. doi: 10.1016/j.omtn.2026.103011
Ren F, Narita R, Rashidi AS, Fruhwürth S, Gao Z, Bak RO et al. ER stress induces caspase-2-tBID-GSDME-dependent cell death in neurons lytically infected with herpes simplex virus type 2. EMBO Journal. 2023 Oct;42(19):e113118. Epub 2023 Aug 30. doi: 10.15252/embj.2022113118
Ravendran S, Hernández SS, König S, Bak RO. CRISPR/Cas-Based Gene Editing Strategies for DOCK8 Immunodeficiency Syndrome. Frontiers in Genome Editing. 2022 Mar;4:793010. doi: 10.3389/fgeed.2022.793010
Qiu L, Ungerbäck JT, Bennett EP, Bak RO. Biologic Therapies for Alleviating Neurodegeneration in Lysosomal Storage Diseases. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 2026 Sept 14. Epub 2026 Sept 14. doi: 10.1007/s40259-026-00804-x
Nitulescu AM, Du W, Glaser V, Kath J, Aird EJ, Cullot G et al. Single-stranded HDR templates with truncated Cas12a-binding sequences improve knock-in efficiencies in primary human T cells. Molecular Therapy Nucleic Acids. 2025 Jun;36(2):102568. doi: 10.1016/j.omtn.2025.102568
Nascimento Lopes Primo M, Bak RO, Mikkelsen JG. Lentiviral vectors for cutaneous RNA managing. Experimental Dermatology. 2012;21(3):162-70. doi: 10.1111/j.1600-0625.2011.01436.x
Mikkelsen NS, Hernandez SS, Jensen TI, Schneller JL, Bak RO. Enrichment of transgene integrations by transient CRISPR activation of a silent reporter gene. Molecular Therapy Methods and Clinical Development. 2023 Jun;29:1-16. doi: 10.1016/j.omtm.2023.02.010
Mikkelsen NS, Bak RO. Enrichment strategies to enhance genome editing. Journal of Biomedical Science. 2023 Dec;30(1):51. doi: 10.1186/s12929-023-00943-1
Martin RM, Ikeda K, Cromer MK, Uchida N, Nishimura T, Romano R et al. Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination. Cell Stem Cell. 2019 May 2;24(5):821-828.e5. doi: 10.1016/j.stem.2019.04.001
Lisle TL, Jacobsen EB, Ahmad SM, Met Ö, Bak RO, Andersen MH. Engineering T cells with a novel PD-L1-specific TCR targeting immune and cancer cells. Signal Transduction and Targeted Therapy. 2026 Dec;11(1):246. doi: 10.1038/s41392-026-02798-y
Laustsen A, Bak RO. Electroporation-Based CRISPR/Cas9 Gene Editing Using Cas9 Protein and Chemically Modified sgRNAs. In Luo Y, editor, Methods in Molecular Biology: Methods and protocols. New York: Springer Science+Business Media. 2019. p. 127-134. (Methods in Molecular Biology, Vol. 1961). doi: 10.1007/978-1-4939-9170-9_9
Lattanzi A, Camarena J, Lahiri P, Segal H, Srifa W, Vakulskas CA et al. Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease. Science Translational Medicine. 2021 Jun;13(598):eabf2444. doi: 10.1126/scitranslmed.abf2444
Jensen TI, Mikkelsen NS, Gao Z, Foßelteder J, Pabst G, Axelgaard E et al. Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi. Genome Research. 2021 Nov;31(11):2120-2130. Epub 2021 Aug 18. doi: 10.1101/gr.275607.121
Jakobsen MR, Bak RO, Andersen A, Berg RK, Jensen SB, Tengchuan J et al. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proceedings of the National Academy of Sciences (PNAS). 2013 Oct 23. doi: 10.1073/pnas.1311669110